Tamsulosin

🧮 Dose calculator

Benign prostatic hyperplasia (BPH) · Regimen source: FDA Tamsulosin · 2

• • If no response after 2–4 weeks, 0.8 mg. Do not use 0.4 mg with strong CYP3A4 inhibitors (ketoconazole). If interrupted several days, restart at 0.4. FDA Tamsulosin · 2

Enter age (weight is optional for this regimen).

👥 Special populations

• 🤰 PregnancyUse with caution

  Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Tamsulosin · 8.1

  “Risk Summary Tamsulosin hydrochloride is not indicated for use in women.”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Tamsulosin · 8.2

  “Tamsulosin hydrochloride is not indicated for use in women.”

• 👶 ChildrenSafety not established

  Label: safety and effectiveness in children have not been established. FDA Tamsulosin · 8.4

  “Tamsulosin hydrochloride capsules are not indicated for use in pediatric populations.”

• 👴 Older adultsUse with caution

  Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Tamsulosin · 8.5

  “Of the total number of subjects (1783) in clinical studies of tamsulosin, 36% were 65 years of age and over.”

• ⚥ Females & males of reproductive potentialUse with caution

  Label has advice on pregnancy testing, contraception or fertility for females and males. FDA Tamsulosin · 8.3

  “Infertility Males Abnormal ejaculation including ejaculation failure, ejaculation disorder, retrograde ejaculation, and ejaculation decrease has been associated with tamsulosin hydrochloride [ see Clinical Trials Experience (6.1) ] .”